Susilo Wagino Mulyo
- apnea
- approvals
- May 12, 2026
- 0 Comments
GLP-1 Medications and Sleep Apnea: Navigating FDA Approvals, Insurance Coverage, and Evolving Treatment Paradigms
The landscape of treating obstructive sleep apnea (OSA), a pervasive condition affecting millions, is undergoing a significant transformation with the advent and increasing adoption of glucagon-like peptide-1 receptor agonists (GLP-1s).…
